Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:June 14, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:June 14, 2017Terminated
Condition(s):Multiple MyelomaLast Updated:January 2, 2020Unknown status
Condition(s):High Risk Smoldering Multiple MyelomaLast Updated:December 16, 2020Terminated
Condition(s):Multiple MyelomaLast Updated:February 1, 2024Enrolling by invitation
Condition(s):Multiple Myeloma; Vertebral FractureLast Updated:November 6, 2020Unknown status
Condition(s):Multiple Myeloma in RelapseLast Updated:October 5, 2023Recruiting
Condition(s):Multiple Myeloma; Relapsed and Refractory Multiple MyelomaLast Updated:September 22, 2023Terminated
Condition(s):Multiple Myeloma(MM)Last Updated:June 30, 2022Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:March 24, 2014Completed
Condition(s):Multiple MyelomaLast Updated:April 12, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.